APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sicca Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sicca Syndrome Drug Industry Growth and Trends Forecast to 2032

Report ID 174035340119 December 2025102 pages

Choose your research edition.

Industry ResearchSicca Syndrome Drug Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Sicca Syndrome Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Sicca Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sicca Syndrome Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sicca Syndrome Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Sicca Syndrome Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sicca Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sicca Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sicca Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sicca Syndrome Drug include Novartis AG, GlaxoSmithKline Plc, Biogen, Inc., Amgen Inc., UCB S.A., Toleranzia AB, Redx Pharma Plc, MedImmune, LLC and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sicca Syndrome Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sicca Syndrome Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sicca Syndrome Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sicca Syndrome Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sicca Syndrome Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sicca Syndrome Drug Market by Company

Novartis AG

GlaxoSmithKline Plc

Biogen, Inc.

Amgen Inc.

UCB S.A.

Toleranzia AB

Redx Pharma Plc

MedImmune, LLC

Bristol-Myers Squibb Company

Ampio Pharmaceuticals, Inc.

Akari Therapeutics, Plc

Sicca Syndrome Drug Segment by Type

BMS-986142

Coversin

Filgotinib

Belimumab

LY-3090106

Others

Sicca Syndrome Drug Segment by Application

Hospital

Clinic

Others

Sicca Syndrome Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sicca Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sicca Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sicca Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sicca Syndrome Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sicca Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BMS-986142 Table 2. Major Company of Coversin Table 3. Major Company of Filgotinib Table 4. Major Company of Belimumab Table 5. Major Company of LY-3090106 Table 6. Major Company of Others Table 7. Global Sicca Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Sicca Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 9. Global Sicca Syndrome Drug Sales Market Share in Volume by Type (2021-2026) Table 10. Global Sicca Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 11. Global Sicca Syndrome Drug Sales Market Share in Value by Type (2021-2026) Table 12. Global Sicca Syndrome Drug Price by Type (2021-2026) & (US$/Unit) Table 13. Global Sicca Syndrome Drug Sales by Type (2027-2032) & (W Units) Table 14. Global Sicca Syndrome Drug Sales Market Share in Volume by Type (2027-2032) Table 15. Global Sicca Syndrome Drug Sales by Type (2027-2032) & (US$ Million) Table 16. Global Sicca Syndrome Drug Sales Market Share in Value by Type (2027-2032) Table 17. Global Sicca Syndrome Drug Price by Type (2027-2032) & (US$/Unit) Table 18. North America Sicca Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 19. North America Sicca Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Sicca Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 21. Europe Sicca Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Sicca Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Sicca Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Sicca Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 25. Latin America Sicca Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Sicca Syndrome Drug Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Sicca Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 28. Sicca Syndrome Drug Industry Trends Table 29. Sicca Syndrome Drug Industry Drivers Table 30. Sicca Syndrome Drug Industry Opportunities and Challenges Table 31. Sicca Syndrome Drug Industry Restraints Table 32. Global Sicca Syndrome Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Sicca Syndrome Drug Revenue Market Share by Company (2021-2026) Table 34. Global Sicca Syndrome Drug Sales by Company (2021-2026) & (W Units) Table 35. Global Sicca Syndrome Drug Sales Share by Company (2021-2026) Table 36. Global Sicca Syndrome Drug Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Sicca Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Sicca Syndrome Drug Major Company Production Sites and Headquarters Table 39. Global Sicca Syndrome Drug Company, Product Type & Application Table 40. Global Sicca Syndrome Drug Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Sicca Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Sicca Syndrome Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Sicca Syndrome Drug Sales by Region (2021-2026) & (W Units) Table 45. Global Sicca Syndrome Drug Sales Market Share in Volume by Region (2021-2026) Table 46. Global Sicca Syndrome Drug Sales by Region (2021-2026) & (US$ Million) Table 47. Global Sicca Syndrome Drug Sales Market Share in Value by Region (2021-2026) Table 48. Global Sicca Syndrome Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Sicca Syndrome Drug Sales by Region (2027-2032) & (W Units) Table 50. Global Sicca Syndrome Drug Sales Market Share in Volume by Region (2027-2032) Table 51. Global Sicca Syndrome Drug Sales by Region (2027-2032) & (US$ Million) Table 52. Global Sicca Syndrome Drug Sales Market Share in Value by Region (2027-2032) Table 53. Global Sicca Syndrome Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Sicca Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Sicca Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 56. Global Sicca Syndrome Drug Sales Market Share in Volume by Application (2021-2026) Table 57. Global Sicca Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 58. Global Sicca Syndrome Drug Sales Market Share in Value by Application (2021-2026) Table 59. Global Sicca Syndrome Drug Price by Application (2021-2026) & (US$/Unit) Table 60. Global Sicca Syndrome Drug Sales by Application (2027-2032) & (W Units) Table 61. Global Sicca Syndrome Drug Sales Market Share in Volume by Application (2027-2032) Table 62. Global Sicca Syndrome Drug Sales by Application (2027-2032) & (US$ Million) Table 63. Global Sicca Syndrome Drug Sales Market Share in Value by Application (2027-2032) Table 64. Global Sicca Syndrome Drug Price by Application (2027-2032) & (US$/Unit) Table 65. North America Sicca Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 66. North America Sicca Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Sicca Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 68. Europe Sicca Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Sicca Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Sicca Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Sicca Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 72. Latin America Sicca Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Sicca Syndrome Drug Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Sicca Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis AG Sicca Syndrome Drug Product Portfolio Table 79. Novartis AG Recent Development Table 80. GlaxoSmithKline Plc Company Information Table 81. GlaxoSmithKline Plc Business Overview Table 82. GlaxoSmithKline Plc Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline Plc Sicca Syndrome Drug Product Portfolio Table 84. GlaxoSmithKline Plc Recent Development Table 85. Biogen, Inc. Company Information Table 86. Biogen, Inc. Business Overview Table 87. Biogen, Inc. Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Biogen, Inc. Sicca Syndrome Drug Product Portfolio Table 89. Biogen, Inc. Recent Development Table 90. Amgen Inc. Company Information Table 91. Amgen Inc. Business Overview Table 92. Amgen Inc. Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Amgen Inc. Sicca Syndrome Drug Product Portfolio Table 94. Amgen Inc. Recent Development Table 95. UCB S.A. Company Information Table 96. UCB S.A. Business Overview Table 97. UCB S.A. Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. UCB S.A. Sicca Syndrome Drug Product Portfolio Table 99. UCB S.A. Recent Development Table 100. Toleranzia AB Company Information Table 101. Toleranzia AB Business Overview Table 102. Toleranzia AB Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Toleranzia AB Sicca Syndrome Drug Product Portfolio Table 104. Toleranzia AB Recent Development Table 105. Redx Pharma Plc Company Information Table 106. Redx Pharma Plc Business Overview Table 107. Redx Pharma Plc Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Redx Pharma Plc Sicca Syndrome Drug Product Portfolio Table 109. Redx Pharma Plc Recent Development Table 110. MedImmune, LLC Company Information Table 111. MedImmune, LLC Business Overview Table 112. MedImmune, LLC Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. MedImmune, LLC Sicca Syndrome Drug Product Portfolio Table 114. MedImmune, LLC Recent Development Table 115. Bristol-Myers Squibb Company Company Information Table 116. Bristol-Myers Squibb Company Business Overview Table 117. Bristol-Myers Squibb Company Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Bristol-Myers Squibb Company Sicca Syndrome Drug Product Portfolio Table 119. Bristol-Myers Squibb Company Recent Development Table 120. Ampio Pharmaceuticals, Inc. Company Information Table 121. Ampio Pharmaceuticals, Inc. Business Overview Table 122. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product Portfolio Table 124. Ampio Pharmaceuticals, Inc. Recent Development Table 125. Akari Therapeutics, Plc Company Information Table 126. Akari Therapeutics, Plc Business Overview Table 127. Akari Therapeutics, Plc Sicca Syndrome Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Akari Therapeutics, Plc Sicca Syndrome Drug Product Portfolio Table 129. Akari Therapeutics, Plc Recent Development Table 130. North America Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 131. North America Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 132. North America Sicca Syndrome Drug Sales Market Share by Country (2021-2026) Table 133. North America Sicca Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 134. North America Sicca Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 135. North America Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. North America Sicca Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 137. North America Sicca Syndrome Drug Market Share by Country (2021-2026) Table 138. North America Sicca Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. North America Sicca Syndrome Drug Market Share Forecast by Country (2027-2032) Table 140. Europe Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 141. Europe Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 142. Europe Sicca Syndrome Drug Sales Market Share by Country (2021-2026) Table 143. Europe Sicca Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 144. Europe Sicca Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 145. Europe Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Europe Sicca Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 147. Europe Sicca Syndrome Drug Market Share by Country (2021-2026) Table 148. Europe Sicca Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Europe Sicca Syndrome Drug Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 152. Asia-Pacific Sicca Syndrome Drug Sales Market Share by Country (2021-2026) Table 153. Asia-Pacific Sicca Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 154. Asia-Pacific Sicca Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific Sicca Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 157. Asia-Pacific Sicca Syndrome Drug Market Share by Country (2021-2026) Table 158. Asia-Pacific Sicca Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Asia-Pacific Sicca Syndrome Drug Market Share Forecast by Country (2027-2032) Table 160. Latin America Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 161. Latin America Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 162. Latin America Sicca Syndrome Drug Sales Market Share by Country (2021-2026) Table 163. Latin America Sicca Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 164. Latin America Sicca Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 165. Latin America Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Latin America Sicca Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 167. Latin America Sicca Syndrome Drug Market Share by Country (2021-2026) Table 168. Latin America Sicca Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Latin America Sicca Syndrome Drug Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Sicca Syndrome Drug Sales by Country (2021-2026) & (W Units) Table 172. Middle East and Africa Sicca Syndrome Drug Sales Market Share by Country (2021-2026) Table 173. Middle East and Africa Sicca Syndrome Drug Sales Forecast by Country (2027-2032) & (W Units) Table 174. Middle East and Africa Sicca Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa Sicca Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 177. Middle East and Africa Sicca Syndrome Drug Market Share by Country (2021-2026) Table 178. Middle East and Africa Sicca Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Middle East and Africa Sicca Syndrome Drug Market Share Forecast by Country (2027-2032) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Sicca Syndrome Drug Distributors List Table 183. Sicca Syndrome Drug Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Sicca Syndrome Drug Image Figure 2. Global Sicca Syndrome Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sicca Syndrome Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Sicca Syndrome Drug Sales (2021-2032) & (W Units) Figure 5. BMS-986142 Image Figure 6. Global BMS-986142 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Coversin Image Figure 8. Global Coversin Sales YoY Growth (2021-2032) & (W Units) Figure 9. Filgotinib Image Figure 10. Global Filgotinib Sales YoY Growth (2021-2032) & (W Units) Figure 11. Belimumab Image Figure 12. Global Belimumab Sales YoY Growth (2021-2032) & (W Units) Figure 13. LY-3090106 Image Figure 14. Global LY-3090106 Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Sicca Syndrome Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Sicca Syndrome Drug Market Share by Type 2025 VS 2032 Figure 19. North America Sicca Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 20. North America Sicca Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 21. Europe Sicca Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 22. Europe Sicca Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Sicca Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Sicca Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 25. Latin America Sicca Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Sicca Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Sicca Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Sicca Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Sicca Syndrome Drug Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 33. Clinic Image Figure 34. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 37. Global Sicca Syndrome Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Sicca Syndrome Drug Market Share by Application 2025 VS 2032 Figure 39. North America Sicca Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Sicca Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Sicca Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Sicca Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Sicca Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Sicca Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Sicca Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Sicca Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Sicca Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Sicca Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Sicca Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. North America Sicca Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Sicca Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Sicca Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Sicca Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Europe Sicca Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Sicca Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Sicca Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Sicca Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Asia-Pacific Sicca Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Sicca Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Sicca Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Sicca Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Latin America Sicca Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Sicca Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Sicca Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Sicca Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Middle East and Africa Sicca Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Sicca Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Sicca Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Sicca Syndrome Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Sicca Syndrome Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • BMS-986142
  • Coversin
  • Filgotinib
  • Belimumab
  • LY-3090106
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • GlaxoSmithKline Plc
  • Biogen, Inc.
  • Amgen Inc.
  • UCB S.A.
  • Toleranzia AB
  • Redx Pharma Plc
  • MedImmune, LLC
  • Bristol-Myers Squibb Company
  • Ampio Pharmaceuticals, Inc.
  • Akari Therapeutics, Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sicca Syndrome Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sicca Syndrome Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sicca Syndrome Drug Market by Type
  6. 1.3.1 BMS-986142
  7. 1.3.2 Coversin
  8. 1.3.3 Filgotinib
  9. 1.3.4 Belimumab
  10. 1.3.5 LY-3090106
  11. 1.3.6 Others
  12. 1.4 Global Sicca Syndrome Drug Market Size by Type
  13. 1.4.1 Global Sicca Syndrome Drug Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Sicca Syndrome Drug Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Sicca Syndrome Drug Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Sicca Syndrome Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Sicca Syndrome Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Sicca Syndrome Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Sicca Syndrome Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Sicca Syndrome Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sicca Syndrome Drug Industry Trends
  2. 2.2 Sicca Syndrome Drug Industry Drivers
  3. 2.3 Sicca Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Sicca Syndrome Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sicca Syndrome Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Sicca Syndrome Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Sicca Syndrome Drug Price (2021-2026)
  4. 3.4 Global Sicca Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sicca Syndrome Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Sicca Syndrome Drug Company, Product Type & Application
  7. 3.7 Global Sicca Syndrome Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sicca Syndrome Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sicca Syndrome Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sicca Syndrome Drug Tier 1, Tier 2, and Tier 3
4 Sicca Syndrome Drug Regional Status and Outlook
  1. 4.1 Global Sicca Syndrome Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sicca Syndrome Drug Historic Market Size by Region
  3. 4.2.1 Global Sicca Syndrome Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sicca Syndrome Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sicca Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sicca Syndrome Drug Forecasted Market Size by Region
  7. 4.3.1 Global Sicca Syndrome Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sicca Syndrome Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sicca Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sicca Syndrome Drug by Application
  1. 5.1 Sicca Syndrome Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Sicca Syndrome Drug Market Size by Application
  6. 5.2.1 Global Sicca Syndrome Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sicca Syndrome Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sicca Syndrome Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sicca Syndrome Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sicca Syndrome Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sicca Syndrome Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sicca Syndrome Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sicca Syndrome Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Sicca Syndrome Drug Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Sicca Syndrome Drug Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 Biogen, Inc.
  14. 6.3.1 Biogen, Inc. Company Information
  15. 6.3.2 Biogen, Inc. Business Overview
  16. 6.3.3 Biogen, Inc. Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biogen, Inc. Sicca Syndrome Drug Product Portfolio
  18. 6.3.5 Biogen, Inc. Recent Developments
  19. 6.4 Amgen Inc.
  20. 6.4.1 Amgen Inc. Company Information
  21. 6.4.2 Amgen Inc. Business Overview
  22. 6.4.3 Amgen Inc. Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amgen Inc. Sicca Syndrome Drug Product Portfolio
  24. 6.4.5 Amgen Inc. Recent Developments
  25. 6.5 UCB S.A.
  26. 6.5.1 UCB S.A. Company Information
  27. 6.5.2 UCB S.A. Business Overview
  28. 6.5.3 UCB S.A. Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 UCB S.A. Sicca Syndrome Drug Product Portfolio
  30. 6.5.5 UCB S.A. Recent Developments
  31. 6.6 Toleranzia AB
  32. 6.6.1 Toleranzia AB Company Information
  33. 6.6.2 Toleranzia AB Business Overview
  34. 6.6.3 Toleranzia AB Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Toleranzia AB Sicca Syndrome Drug Product Portfolio
  36. 6.6.5 Toleranzia AB Recent Developments
  37. 6.7 Redx Pharma Plc
  38. 6.7.1 Redx Pharma Plc Company Information
  39. 6.7.2 Redx Pharma Plc Business Overview
  40. 6.7.3 Redx Pharma Plc Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Redx Pharma Plc Sicca Syndrome Drug Product Portfolio
  42. 6.7.5 Redx Pharma Plc Recent Developments
  43. 6.8 MedImmune, LLC
  44. 6.8.1 MedImmune, LLC Company Information
  45. 6.8.2 MedImmune, LLC Business Overview
  46. 6.8.3 MedImmune, LLC Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MedImmune, LLC Sicca Syndrome Drug Product Portfolio
  48. 6.8.5 MedImmune, LLC Recent Developments
  49. 6.9 Bristol-Myers Squibb Company
  50. 6.9.1 Bristol-Myers Squibb Company Company Information
  51. 6.9.2 Bristol-Myers Squibb Company Business Overview
  52. 6.9.3 Bristol-Myers Squibb Company Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bristol-Myers Squibb Company Sicca Syndrome Drug Product Portfolio
  54. 6.9.5 Bristol-Myers Squibb Company Recent Developments
  55. 6.10 Ampio Pharmaceuticals, Inc.
  56. 6.10.1 Ampio Pharmaceuticals, Inc. Company Information
  57. 6.10.2 Ampio Pharmaceuticals, Inc. Business Overview
  58. 6.10.3 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product Portfolio
  60. 6.10.5 Ampio Pharmaceuticals, Inc. Recent Developments
  61. 6.11 Akari Therapeutics, Plc
  62. 6.11.1 Akari Therapeutics, Plc Company Information
  63. 6.11.2 Akari Therapeutics, Plc Business Overview
  64. 6.11.3 Akari Therapeutics, Plc Sicca Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Akari Therapeutics, Plc Sicca Syndrome Drug Product Portfolio
  66. 6.11.5 Akari Therapeutics, Plc Recent Developments
7 North America by Country
  1. 7.1 North America Sicca Syndrome Drug Sales by Country
  2. 7.1.1 North America Sicca Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sicca Syndrome Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Sicca Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sicca Syndrome Drug Market Size by Country
  6. 7.2.1 North America Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sicca Syndrome Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Sicca Syndrome Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sicca Syndrome Drug Sales by Country
  2. 8.1.1 Europe Sicca Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sicca Syndrome Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Sicca Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sicca Syndrome Drug Market Size by Country
  6. 8.2.1 Europe Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sicca Syndrome Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sicca Syndrome Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sicca Syndrome Drug Sales by Country
  2. 9.1.1 Asia-Pacific Sicca Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sicca Syndrome Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sicca Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sicca Syndrome Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sicca Syndrome Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sicca Syndrome Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sicca Syndrome Drug Sales by Country
  2. 10.1.1 South America Sicca Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sicca Syndrome Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Sicca Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sicca Syndrome Drug Market Size by Country
  6. 10.2.1 South America Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sicca Syndrome Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Sicca Syndrome Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sicca Syndrome Drug Sales by Country
  2. 11.1.1 Middle East and Africa Sicca Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sicca Syndrome Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sicca Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sicca Syndrome Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Sicca Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sicca Syndrome Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sicca Syndrome Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sicca Syndrome Drug Value Chain Analysis
  2. 12.1.1 Sicca Syndrome Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sicca Syndrome Drug Production Mode & Process
  7. 12.2 Sicca Syndrome Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sicca Syndrome Drug Distributors
  10. 12.2.3 Sicca Syndrome Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst